Callan JMB launches logistics services in India with Pune warehouse

SPRING BRANCH, Texas - Callan JMB INC. (NASDAQ:CJMB), a $23.7 million market cap healthcare logistics provider that has seen its stock surge over 30% in the past six months, announced Tuesday the formation of Callan JMB Services (India) Private Limited to offer logistics services in India, with plans to establish a warehouse in Pune, Maharashtra. According to InvestingPro analysis, the company appears overvalued at current levels.

The new facility will provide storage and distribution of pharmaceuticals at various temperature ranges, including capabilities for -80°C storage needed for tissue samples in clinical trials, according to a company press release.

The Indian subsidiary, incorporated on June 20, will distribute pharmaceutical and wellness products within India while also assisting Indian companies in establishing manufacturing operations in the United States.

The company has already secured an agreement with Walker’s Pharmaceuticals Ltd. and is working with Brihans Natural Products Ltd. to help both firms establish U.S. manufacturing plants and distribute their products in the American market.

"Our successful track record of shipping tissue samples from India to the U.S. for clinical trials demonstrated the need for dedicated operations in India to streamline the process and reduce costs," said Wayne Williams, Founder and CEO of Callan JMB.

The company stated it will leverage its cold chain logistics expertise to import tissue samples for clinical trials and active pharmaceutical ingredients from India to the U.S., while also facilitating distribution within the Indian market.

Callan JMB describes itself as an integrative logistics company providing fulfillment, storage, monitoring, and cold chain logistics services for the healthcare industry and emergency management agencies.

In other recent news, Callan JMB Inc. has announced a joint venture with Revival Health Inc. to enhance healthcare logistics. This collaboration aims to create an advanced supply chain for health and wellness products, focusing on personalized healthcare. Callan JMB will leverage its expertise in cold chain logistics and bioservices, while Revival Health will contribute its consumer-centric approach to preventive care. The partnership is set to develop an infrastructure that ensures efficient product distribution while maintaining safety and efficacy standards. Wayne Williams, CEO of Callan JMB, emphasized the venture’s potential to transform healthcare product availability in the U.S. Robb Fujioka, CEO of Revival Health, noted the initiative’s role in making healthy living more accessible. Callan JMB’s Coldchain Technology Services will support the venture with transportation, warehousing, and regulatory compliance to maintain product integrity. This strategic move addresses the challenge of delivering preventive care at scale, reflecting both companies’ commitment to improving healthcare distribution and accessibility.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.